Table 2.
Characteristic | Cluster 1 | Cluster 2 | P-value |
---|---|---|---|
Samples (n) | 136 | 112 | |
Age, median (IQR) | 67 (64, 72) | 69 (62, 73) | 0.632 |
T stage, n (%) | <0.001 | ||
T1 | 39 (17.5%) | 12 (5.4%) | |
T2 | 42 (18.8%) | 34 (15.2%) | |
T3 | 41 (18.4%) | 51 (22.9%) | |
T4 | 0 (0%) | 4 (1.8%) | |
Gleason score (GS), n (%) | <0.001 | ||
GS = 6 | 37 (14.9%) | 5 (2%) | |
GS = 7 | 60 (24.2%) | 39 (15.7%) | |
GS = 8 | 26 (10.5%) | 26 (10.5%) | |
GS = 9 | 13 (5.2%) | 42 (16.9%) | |
Biochemical recurrence, n (%) | 0.005 | ||
No | 115 (46.4%) | 77 (31%) | |
Yes | 21 (8.5%) | 35 (14.1%) | |
Metastasis, n (%) | 0.041 | ||
No | 129 (52%) | 97 (39.1%) | |
Yes | 7 (2.8%) | 15 (6%) |
IQR, interquartile range; GS, Gleason score.